InsideArbitrage Event Driven Monitor – February 5, 2025

Merger Arbitrage

1. NARI: Inari Medical (NARI) announced that the companies filed all required Notification and Report Forms under the HSR Act for the merger, with the Antitrust Division and the FTC on January 17, 2025. On February 3, 2025, the waiting period under the HSR Act applicable to the Offer expired.
2. VCSA: Davidson Kempner Capital Management, which owns approximately 20% of Vacasa (VCSA), has proposed acquiring all outstanding shares of the company not already owned by Davidson Kempner at $5.25 per share in cash. The firm has engaged Moelis & Co. as its financial advisor and Dechert as its legal counsel for the proposal.
3. CYTH: Cyclo Therapeutics (CYTH) and Rafael Holdings (RFL) announced that they have now amended the merger termination date to March 31, 2025 via an amendment. Initially, the deal was expected to close on February 15, 2025 and it is still subject to the SEC clearance of Rafael’s Form S-4 registration statement.

You can check out new deals, all deal updates, and spreads on active deals in our Merger Arbitrage Tool for premium members here.

Only plus or premium subscribers can access this post. Subscribe today.